![]() |
市場調查報告書
商品編碼
1803044
全球 CBD機能水市場預測(至 2032 年):按產品類型、成分、配方、包裝、分銷管道、應用和地區進行分析CBD Functional Water Market Forecasts to 2032 - Global Analysis By Product Type, Composition, Formulation, Packaging, Distribution Channel, Application and By Geography |
根據 Stratistics MRC 的數據,全球 CBD機能水市場規模預計在 2025 年將達到 23.3 億美元,預計到 2032 年將達到 138 億美元,預測期內複合年成長率為 29%。 CBD機能水是一種注入了大麻二酚 (CBD) 的健康飲料,CBD 是一種從大麻中提取的非精神活性化合物。
它們將補水與潛在的治療功效相結合,例如緩解壓力、抗發炎和提高注意力。它們採用奈米乳液或水溶性CBD技術配製而成,可提高生物利用度,從而實現高效吸收。 CBD機能水通常富含維生素、礦物質或適應原,目標客戶是注重健康的消費者,他們尋求天然、無毒的日常健康和恢復替代品。
日益成長的健康與保健趨勢
隨著人們尋求天然替代品來管理壓力、焦慮和炎症,CBD水因其公認的治療功效和便利性而逐漸成為人們的首選。健康趨勢與功能性補水的融合,促使製造商將CBD水定位為一種生活方式產品,而非藥物補充劑。此外,潔淨標示運動和對植物來源成分的偏好正在推動市場成長,尤其是在千禧世代和注重健康的消費者群體中。
消費者誤解和缺乏教育
許多消費者仍然將CBD與精神活性作用聯繫在一起,這使得他們猶豫是否要使用它。不一致的標籤檢視和不明確的劑量進一步造成了混淆,並削弱了人們對產品功效的信任。此外,跨地區缺乏標準化的法律規範,使得行銷工作更加複雜,並限制了產品在主流零售通路的知名度。總而言之,這些因素阻礙了CBD的市場滲透,並降低了消費者的轉換率。
有針對性的產品供應和創新
諸如奈米乳化CBD以提高生物有效性、無糖配方以及融合了適應原和維生素的混合產品等創新技術正日益受到歡迎。各大品牌也正在探索個人化包裝與訂閱模式,以提升消費者參與。隨著監管日益清晰,企業可以利用數位平台和網紅行銷來教育小眾受眾,並擴大其在尚未開發地區的影響力。
嚴格的規定和潛在的禁令
出於對安全性、標籤準確性和長期健康影響的擔憂,一些國家的監管機構持續審查CBD產品,有些甚至實施限制或直接禁止。這種不確定性會影響投資決策,並延遲產品上市。此外,與THC含量、採購透明度和製造標準相關的嚴格合規要求可能會增加營運複雜性,並阻礙新進入者。
疫情對CBD機能水市場產生了雙重影響。一方面,供應鏈中斷和監管瓶頸導致產品供應延遲,分銷受阻。另一方面,壓力水平上升以及對免疫力和心理健康的日益關注,導致對健康飲料(包括注入CBD的飲料)的需求激增。消費者傾向於選擇便利的居家解決方案來應對焦慮和睡眠障礙,這促進了線上銷售和直銷管道的銷售。
預計無味/中性 CBD 水市場在預測期內將佔據最大佔有率
由於其用途廣泛且受到消費者的廣泛青睞,無味/中性CBD水預計將在預測期內佔據最大的市場佔有率。這類產品通常受到尋求不添加糖、人工香料或遮罩劑的治療功效人士的青睞。其極簡成分符合潔淨標示的偏好,易於融入日常補水習慣。此外,中性CBD水可作為客製化消費的基礎,使用者可與其他飲料或補充品混合,進一步提升其效用。
預計 CBD隔離群機能水細分市場在預測期內的複合年成長率最高
由於其純度和合規性優勢,CBD隔離群機能水市場預計將在預測期內實現最高成長率。與全光譜和頻譜配方不同,隔離群產品不含THC,這使得它們在大麻監管嚴格的地區更容易被接受。精準健康和針對性配方的需求日益成長,促使製造商投資隔離群技術,該技術可提供一致的劑量並提高貨架穩定性。此細分市場也受惠於水溶性CBD輸送系統的進步,這提高了產品的吸收率和消費者滿意度。
由於監管發展良好、消費者意識高漲以及濃厚的健康文化,北美預計將在預測期內佔據最大市場佔有率。知名CBD品牌的出現以及超級市場、專賣店和電商平台的廣泛零售,進一步鞏固了該地區的主導地位。此外,持續進行的關於CBD健康益處的研究和積極的行銷宣傳活動正在增強消費者信心。
預計亞太地區在預測期內將呈現最高的複合年成長率,這得益於可支配收入的提高、城市人口的擴張以及人們對替代醫學日益成長的興趣。受消費者態度轉變和法律規範不斷發展的推動,日本、韓國和澳洲等國家正逐步向基於CBD的產品開放。該地區充滿活力的飲料行業和強大的創新文化正在推動產品快速多樣化。
According to Stratistics MRC, the Global CBD Functional Water Market is accounted for $2.33 billion in 2025 and is expected to reach $13.8 billion by 2032 growing at a CAGR of 29% during the forecast period. CBD functional water is a wellness beverage infused with cannabidiol (CBD), a non-psychoactive compound derived from hemp. It combines hydration with potential therapeutic benefits such as stress relief, anti-inflammatory support, and improved focus. Formulated through nanoemulsion or water-soluble CBD technology, it enhances bioavailability for efficient absorption. Often enriched with vitamins, minerals, or adaptogens, CBD functional water targets health-conscious consumers seeking natural, non-intoxicating alternatives for daily wellness and recovery.
Growing health and wellness trend
As individuals seek natural alternatives to manage stress, anxiety, and inflammation, CBD water is emerging as a preferred choice due to its perceived therapeutic benefits and ease of consumption. The convergence of wellness trends with functional hydration is encouraging manufacturers to position CBD water as a lifestyle product rather than a medicinal supplement. Additionally, the clean-label movement and preference for plant-based ingredients are reinforcing market growth, especially among millennials and health-focused consumers.
Consumer misconceptions and lack of education
Many consumers still associate CBD with psychoactive effects, leading to hesitation in adoption. Inconsistent labeling and unclear dosage guidelines further contribute to confusion, undermining trust in product efficacy. Moreover, the absence of standardized regulatory frameworks across regions complicates marketing efforts and restricts product visibility in mainstream retail channels. These factors collectively hinder broader market penetration and slow down consumer conversion rates.
Targeting specific demographics & innovation in product offerings
Innovations such as nano-emulsified CBD for enhanced bioavailability, sugar-free formulations, and hybrid products combining adaptogens or vitamins are gaining traction. Brands are also exploring personalized packaging and subscription models to increase consumer engagement. As regulatory clarity improves, companies can leverage digital platforms and influencer marketing to educate niche audiences and expand their footprint in untapped regions.
Stringent regulations and potential bans
Regulatory bodies in several countries continue to scrutinize CBD-infused products, with some imposing restrictions or outright bans due to concerns over safety, labeling accuracy, and long-term health effects. This unpredictability affects investment decisions and delays product launches. Additionally, stringent compliance requirements related to THC content, sourcing transparency, and manufacturing standards increase operational complexity and may deter new entrants from entering the market.
The pandemic had a dual impact on the CBD functional water market. On one hand, supply chain disruptions and regulatory bottlenecks delayed product availability and hindered distribution. On the other, heightened stress levels and increased focus on immunity and mental health created a surge in demand for wellness beverages, including CBD-infused options. Consumers gravitated toward convenient, at-home solutions to manage anxiety and sleep disorders, boosting online sales and direct-to-consumer channels.
The unflavoured / neutral CBD water segment is expected to be the largest during the forecast period
The unflavoured / neutral CBD water segment is expected to account for the largest market share during the forecast period due to its versatility and broad consumer appeal. These products are often preferred by individuals seeking therapeutic benefits without added sugars, artificial flavors, or masking agents. Their minimalist composition aligns with clean-label preferences and allows for easier integration into daily hydration routines. Additionally, neutral CBD water serves as a base for customized consumption, enabling users to mix it with other beverages or supplements, further enhancing its utility.
The CBD isolate functional water segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the CBD isolate functional water segment is predicted to witness the highest growth rate driven by its purity and compliance advantages. Unlike full-spectrum or broad-spectrum formulations, isolate products contain no THC, making them more acceptable in regions with strict cannabis regulations. The growing demand for precision wellness and targeted formulations is encouraging manufacturers to invest in isolate technologies that offer consistent dosing and improved shelf stability. This segment is also benefiting from advancements in water-soluble CBD delivery systems, which enhance absorption and consumer satisfaction.
During the forecast period, the North America region is expected to hold the largest market share attributed favorable regulatory developments, high consumer awareness, and a robust wellness culture. The presence of established CBD brands and widespread retail availability across supermarkets, specialty stores, and e-commerce platforms contributes to regional dominance. Additionally, ongoing research into CBD's health benefits and proactive marketing campaigns are fostering consumer confidence.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by rising disposable incomes, expanding urban populations, and growing interest in alternative health solutions. Countries like Japan, South Korea, and Australia are gradually opening up to CBD-based products, driven by changing consumer attitudes and evolving regulatory frameworks. The region's dynamic beverage industry and strong innovation culture are enabling rapid product diversification.
Key players in the market
Some of the key players in CBD Functional Water Market include Charlotte's Web Holdings Inc., CV Sciences Inc., Gaia Botanicals LLC, American Premium Water Corp., Alkaline Water Company Inc., Recess, Cloud Water Brands, CBD Living, Cannaki Beverage Inc., VYBES, Day One Beverages, Miraflora Naturals Inc., Oleo Inc. and Hemp Hydrate.
In August 2025, CV Sciences Inc. debuted Ignite, a new men's performance supplement focused on vitality, recovery, libido, and focus bridging their wellness and nutraceutical innovation.
In March 2025, CV Sciences Inc. introduced its new Aura Collection THC Fizz Tablets, expanding its cannabinoid product line with innovative functional beverage formats.
In February 2025, Charlotte's Web's DeFloria, a joint venture with Ajna BioSciences and BAT, received FDA clearance to begin Phase 2 clinical trials for AJA001, a botanical solution targeting irritability in autism. Charlotte's Web holds exclusive manufacturing rights for the drug if approved, offering significant future upside.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.